Tag: Pharmaceutical Deal

Lundbeck acquires Prexton Therapeutics

By acquiring Prexton, Lundbeck will obtain global rights of an attractive compound which currently is in clinical phase II testing for symptomatic treatment of OFF-time reduction in Parkinson's disease and dyskinesia.

Arix Bioscience and Fosun International will jointly develop new therapies

molecule dev
Arix Bioscience, a global healthcare and life science company headquartered in London, and Fosun International Limited, announced a strategic agreement to develop and commercialise new clinical therapies for patients.

Bristol-Myers Squibb started a new collaboration with Nektar Therapautics

Bristol-Myers Squibb Company and Nektar Therapeutics announced a new clinical collaboration to evaluate Bristol-Myers Squibb’s Opdivo (nivolumab) with Nektar’s investigational medicine, NKTR-214

Universal Cells becomes a subsidiary of Astellas

Astellas will gain Universal Cells' proprietary Universal Donor Cell technology to create cell therapy products that do not require Human Leukocyte Antigen (HLA) matching

Teva will receive $700 million from Allergan

Allergan PLC, headquartered in Dublin, Ireland, a global pharmaceutical company, will pay Teva Pharmaceutical Industries Ltd. $700 million to dismiss a dispute between the two companies

Partner Therapeutics buys global rights for an immuno-stimulant from Sanofi

US cancer startup Partner Therapeutics, Inc. (PTx) announced that it has acquired the global rights to develop, manufacture, and commercialize Leukine (sargramostim) from Sanofi

Seattle Genetics merges with Cascadian Therapeutics

cancer lab diagnostic
Seattle Genetics, Inc. and Cascadian Therapeutics, Inc. announced the signing of a definitive merger agreement under which Seattle Genetics has agreed to acquire Cascadian Therapeutics

Eurofins Agroscience Services purchased a global CRO Selcia

Eurofins Agroscience Services, an agrochemical manufacturer, informed that it has acquired Selcia Limited, a global provider of custom radiolabelling and integrated drug discovery services

Dechra Pharmaceuticals buys two European pharma companies

veterinary drug
Dechra Pharmaceuticals, a UK veterinary company, announced the acquisition of two European pharmaceutical business as well as a share placing to part-fund the purchases

Astellas accomplished the acquisition of US biotech Mitobridge

Astellas Pharma Inc., a leading Japanese pharmaceutical company, announced that it has completed the acquisition of Mitobridge, Inc., and Mitobridge has become a wholly owned subsidiary of Astellas.

Abcam announced an exclusive licensing deal with Roche

Abcam, a global leader in the supply of life science research tools, announced that it has entered into a definitive license agreement with Roche

Celgene Corporation acquires Juno Therapeutics

Celgene Corporation and Juno Therapeutics, Inc. today announced the signing of a definitive merger agreement in which Celgene has agreed to acquire Juno

Sanofi buys Bioverativ biopharmaceutical company

Sanofi and Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia, have entered into a agreement under which Sanofi will acquire all of the outstanding shares of Bioverativ

CRO Optimapharm buys Czech company MKS Research

Optimapharm, following the global trend of consolidating market positions of clinical research organizations, acquired the Czech CRO company MKS Research

Celgene announced the buyout of Impact Biomedicines

Celgene Corporation and Impact Biomedicines announced the signing of a definitive agreement in which Celgene will acquire Impact Biomedicines

Mallinckrodt acquires Sucampo Pharmaceuticals

Mallinckrodt and Sucampo Pharmaceuticalsannounced that they have entered into an agreement under which Mallinckrodt will acquire Sucampo